{"id":"https://openalex.org/W2296828792","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.5505","title":"Cetuximab, docetaxel, and cisplatin (TPEx) as first-line treatment in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Final results of phase II trial GORTEC 2008-03.","display_name":"Cetuximab, docetaxel, and cisplatin (TPEx) as first-line treatment in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Final results of phase II trial GORTEC 2008-03.","alternate_titles":[],"publication_year":2012,"publication_date":"2012-05-20","ids":{"openalex":"https://openalex.org/W2296828792","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.5505","mag":"2296828792"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.30.15_suppl.5505","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.5505","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.5505","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2296828792"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008235770","display_name":"Jo\u00ebl Guigay","orcid":"https://orcid.org/0000-0002-5654-6411","observed_orcids":["https://orcid.org/0000-0002-5654-6411"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joel Guigay","raw_affiliation_strings":["Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028065894","display_name":"J\u00e9r\u00f4me Fayette","orcid":"https://orcid.org/0000-0002-8126-7019","observed_orcids":["https://orcid.org/0000-0002-8126-7019","https://orcid.org/0000-0003-4126-1664"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jerome Fayette","raw_affiliation_strings":["Centre L\u00e9on B\u00e9rard, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre L\u00e9on B\u00e9rard, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025440341","display_name":"Anne-Fran\u00e7oise Dillies","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124119","display_name":"Centre Jean Perrin","ror":"https://ror.org/02pwnhd33","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210124119"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anne-Francoise Dillies","raw_affiliation_strings":["Centre Jean Perrin, Clermont-Ferrand, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Jean Perrin, Clermont-Ferrand, France","institution_ids":["https://openalex.org/I4210124119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106266597","display_name":"Christian Sire","orcid":"https://orcid.org/0000-0001-9884-8437","observed_orcids":["https://orcid.org/0000-0001-9884-8437"]},"institutions":[{"id":"https://openalex.org/I4210099266","display_name":"Centre Hospitalier de Bretagne Sud","ror":"https://ror.org/011jgpb07","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210099266"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christian Sire","raw_affiliation_strings":["CH de Bretagne Sud, Lorient, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CH de Bretagne Sud, Lorient, France","institution_ids":["https://openalex.org/I4210099266"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018131884","display_name":"Joseph N. Kerger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joseph N. Kerger","raw_affiliation_strings":["CHU UCL de Mont-Godinne, Yvoir, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU UCL de Mont-Godinne, Yvoir, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104090077","display_name":"Isabelle Tennevet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152093","display_name":"Centre Henri Becquerel","ror":"https://ror.org/00whhby07","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210141925","https://openalex.org/I4387152093"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Isabelle Tennevet","raw_affiliation_strings":["Centre Henri Becquerel, Rouen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Henri Becquerel, Rouen, France","institution_ids":["https://openalex.org/I4387152093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066800365","display_name":"Jean\u2010Pascal Machiels","orcid":"https://orcid.org/0000-0001-6369-9742","observed_orcids":["https://orcid.org/0000-0001-6369-9742"]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Pascal H. Machiels","raw_affiliation_strings":["Clinique Universitaires St-Luc, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinique Universitaires St-Luc, Brussels, Belgium","institution_ids":["https://openalex.org/I1315288073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062822105","display_name":"Sylvie Zanetta","orcid":"https://orcid.org/0000-0003-2002-0255","observed_orcids":["https://orcid.org/0000-0003-2002-0255"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sylvie Zanetta","raw_affiliation_strings":["Centre Georges Fran\u00e7ois Leclerc, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Georges Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025984718","display_name":"Y. Pointreau","orcid":"https://orcid.org/0000-0002-2442-2879","observed_orcids":["https://orcid.org/0000-0002-2442-2879"]},"institutions":[{"id":"https://openalex.org/I4210095477","display_name":"Centre Hospitalier Universitaire de Tours","ror":"https://ror.org/00jpq0w62","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210095477"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoann Pointreau","raw_affiliation_strings":["CHRU de Tours, Tours, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHRU de Tours, Tours, France","institution_ids":["https://openalex.org/I4210095477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006765714","display_name":"L. Bozec Le Moal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156825","display_name":"H\u00f4pital Foch","ror":"https://ror.org/058td2q88","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210156825"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laurence Bozec Le Moal","raw_affiliation_strings":["Hopital Foch, Suresnes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hopital Foch, Suresnes, France","institution_ids":["https://openalex.org/I4210156825"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033210880","display_name":"Lydia Brugel Ribere","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159273","display_name":"H\u00f4pital Intercommunal de Cr\u00e9teil","ror":"https://ror.org/04n1nkp35","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210159273"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lydia Brugel Ribere","raw_affiliation_strings":["CHIC, Creteil, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHIC, Creteil, France","institution_ids":["https://openalex.org/I4210159273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063533532","display_name":"Stefanie Henry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stefanie Henry","raw_affiliation_strings":["Clinique Sainte-Elisabeth, Namur, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinique Sainte-Elisabeth, Namur, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010931431","display_name":"St\u00e9phane Temam","orcid":"https://orcid.org/0000-0002-5590-5339","observed_orcids":["https://orcid.org/0000-0002-5590-5339"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"St\u00e9phane Temam","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"last","author":{"id":null,"display_name":"GORTEC","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"GORTEC","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"15_suppl","first_page":"5505","last_page":"5505"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11669","display_name":"Head and Neck Surgical Oncology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":1.0},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.8489999771118164},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.7269999980926514},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7559999823570251},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9779999852180481},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.921999990940094},{"id":"https://openalex.org/keywords/lenograstim","display_name":"lenograstim","score":0.7630000114440918},{"id":"https://openalex.org/keywords/g-csf-support","display_name":"G-CSF support","score":0.828000009059906},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.5220000147819519},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.5400000214576721}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9461843967437744},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9238009452819824},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8560433983802795},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.6700109839439392},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6688187718391418},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5673090815544128},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5610529780387878},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.49276140332221985},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4926467537879944},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.46390101313591003},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4583832621574402},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4538889229297638},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.41822510957717896},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.41200053691864014},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3450636863708496},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33925339579582214},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2641134262084961},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.08284416794776917},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.06147193908691406}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2012.30.15_suppl.5505","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.5505","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.5505","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4244745225","https://openalex.org/W1884504792","https://openalex.org/W4213208630","https://openalex.org/W2165385965","https://openalex.org/W2980082933","https://openalex.org/W2964016023","https://openalex.org/W2268922826","https://openalex.org/W3134959030","https://openalex.org/W1802303469"],"abstract_inverted_index":{"5505":[0],"Background:":[1],"Cetuximab":[2,23],"in":[3,14,51,220,333],"combination":[4,46],"with":[5,20,53,139,272,336],"platinum":[6],"and":[7,24,39,44,80,97,183,215,229,246,250,296,322],"5FU":[8],"(PFEx)":[9],"has":[10],"become":[11],"a":[12,325],"standard":[13],"first-line":[15,49,331],"treatment":[16,50,332],"of":[17,41,74,104,148,263],"patients":[18],"(pts)":[19],"R/M":[21,54,70,337],"SCCHN.":[22,55,338],"taxane":[25],"combinations":[26],"have":[27,61,188],"shown":[28],"promising":[29],"activity.":[30],"This":[31],"multicenter":[32],"phase":[33],"II":[34],"study":[35],"evaluates":[36],"the":[37],"efficacy":[38],"safety":[40],"cetuximab,":[42],"docetaxel":[43,87],"cisplatin":[45,75,92],"(TPEx)":[47],"as":[48,128,330],"pts":[52,187,202,222,226,231,335],"Methods:":[56],"Pts":[57,85],"were":[58,172,217,248,285],"required":[59],"to":[60,157,308],"WHO":[62],"PS":[63],"0-1,":[64],"no":[65,81],"prior":[66,82],"systemic":[67],"therapy":[68,130,265],"for":[69,206,328],"SCCHN,":[71],"cumulative":[72],"dose":[73],"less":[76],"than":[77],"300":[78],"mg/m\u00b2":[79,89,94,100,109,123],"anti-EGFR":[83],"therapy.":[84],"received":[86],"75":[88,93],"day":[90,95,102],"1,":[91],"1":[96,103,106,303],"cetuximab":[98,121],"(400":[99],"on":[101,310],"cycle":[105,147],"then":[107,118],"250":[108],"weekly),":[110],"repeated":[111],"every":[112,124,153],"21":[113,225],"days":[114],"x":[115],"4":[116,230],"cycles":[117],"followed":[119],"by":[120],"500":[122],"2":[125],"weeks":[126],"(wks)":[127],"maintenance":[129,264],"until":[131],"disease":[132,214],"progression":[133,216],"or":[134],"unacceptable":[135],"toxicity.":[136],"G-CSF":[137,273],"support":[138],"lenograstim":[140],"150":[141],"\u00b5g/m\u00b2/day":[142],"was":[143,151,162,237,257,266,270,301,306],"delivered":[144],"after":[145,261],"each":[146],"chemotherapy.":[149],"Response":[150],"assessed":[152],"6":[154],"wks,":[155],"according":[156],"RECIST.":[158],"The":[159,243,254],"primary":[160],"endpoint":[161],"objective":[163],"response":[164],"rate":[165],"(ORR)":[166],"at":[167,208],"12":[168,197,209],"wks.":[169],"Secondary":[170],"endpoints":[171],"safety,":[173],"best":[174],"overall":[175,180,235],"response,":[176,212],"progression-free":[177],"survival":[178,181],"(PFS),":[179],"(OS)":[182],"biomarkers.":[184],"Results:":[185],"54":[186],"been":[189],"enrolled:":[190],"52":[191],"males,":[192],"median":[193,244],"age":[194],"57.8years":[195],"(28-69),":[196],"(22.2%)":[198],"oropharynx,":[199],"55%":[200],"metastatic.48":[201],"could":[203],"be":[204,324],"evaluated":[205],"ORR":[207,236],"wks:":[210],"partial":[211],"stable":[213],"respectively":[218],"found":[219],"23":[221],"(PR":[223],"47.9%),":[224],"(SD":[227],"43.7%)":[228],"(PD":[232],"8.3%).":[233],"Best":[234],"54%":[238],"(1":[239],"CR,":[240],"27":[241],"PR).":[242],"PFS":[245,260],"OS":[247,256],"7.1":[249],"15.3":[251],"months,":[252],"respectively.":[253],"1-year":[255],"58.6%.":[258],"Median":[259],"start":[262],"4.2":[267],"months.":[268],"Toxicity":[269],"manageable":[271],"support.":[274],"Treatment":[275],"related":[276,307],"toxicities":[277],"included":[278],"G4":[279],"neutropenia":[280,298],"(n=3).":[281],"Grade":[282],"3":[283],"events":[284],"skin":[286],"rash":[287],"(n=5),":[288],"hypersensitivity":[289],"reaction":[290],"(n=3),":[291],"mucositis":[292],"(n=1),":[293],"fatigue":[294],"(n=1)":[295],"febrile":[297],"(n=1).":[299],"Alopecia":[300],"common.":[302],"toxic":[304],"death":[305],"sepsis":[309],"feeding":[311],"tube.":[312],"Conclusions:":[313],"Efficacy":[314],"analysis":[315],"demonstrates":[316],"that":[317],"TPEx":[318],"regimen":[319],"is":[320],"effective":[321],"might":[323],"relevant":[326],"substitute":[327],"PFEx":[329],"fit":[334]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2296828792","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2020,"cited_by_count":8},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
